Low-high and high-low biphasic injection forms in computed tomography examinations of the upper abdomen

Purpose: To analyze the influence of different biphasic and monophasic injection rate protocols in abdominal computed tomography (CT).

Material and Methods: A randomized, consecutive, parallel group study was designed and conducted in 60 patients studied with the same CT helical protocol. Patients were randomly distributed into three groups: (A) monophasic (120 ml at 2.5 ml/s); (B) low-high biphasic (120 ml, first 60 ml at a rate of 2 ml/s, the other 60 ml at 2.5 ml/s); and (C) high-low biphasic (120 ml, first 60 ml at a rate of 2.5 ml/s, the other 60 ml at 2 ml/s). All patients were injected with 300 mg I/ml non-ionic contrast media at a fixed delay time of 55 s. Contrast enhancement efficacy was evaluated by attenuation coefficient measurements.

Results: Although non-significant, monophasic protocol enhancements were higher than biphasic protocol enhancements in all measurements except aortic bifurcation (p = 0.003). At this level, biphasic protocols obtained an increased mean enhancement from 7.6% to 2.5% compared to monophasic protocols.

Conclusion: Monophasic contrast agent injection in helical CT of the upper abdomen produces a higher enhancement of parenchymal and venous structures. No significant difference was observed between low-high and high-low biphasic protocols.     

CT pulmonary angiography with a macromolecular contrast medium: a comparative study versus iobitridol in rabbits

RATIONALE AND OBJECTIVES: To compare the pharmacokinetics of a new macromolecular iodinated contrast medium, prototype P743, with a standard contrast agent (iobitridol) for spiral computed tomography pulmonary angiography in rabbits. METHODS: Manual injection was first used to test the performance of P743 even in cases of nonoptimal bolus timing. Then a protocol was designed to compare vessel enhancement in both first-pass and delayed scans for the two contrast agents with the help of a power injector. RESULTS: With manual fast injection, the first pass of iobitridol was observed only on proximal scans. Conversely, opacification of vessels was maintained during three spiral scans with P743 under the same injection conditions. When optimal bolus timing was performed, higher vessel enhancement was observed during bolus first pass with iobitridol (iodine dosage 250 mg I/kg) compared with P743 (150 mg I/kg). However, during the postbolus phase, the decrease in attenuation values was markedly faster with iobitridol than with P743. CONCLUSIONS: This study confirmed that P743 remains more intravascular than iobitridol, which may have clinical implications for the diagnosis of pulmonary embolism, for example.     

Improved contrast enhancement with a positive pressure drip infusion method and 350 mg I/ml high concentration contrast media in routine contrast enhanced CT

Sixty cases of routine contrast enhanced CT were analyzed about the utilities of positive pressure drip infusion method using high concentration contrast media 350 mgI/ml, 100 ml. They were divided into three groups and each twenty cases were received positive pressure drip infusion method using Iohexol 350 mg/ml, 100 ml (350PP), positive pressure drip infusion method using Iohexol 300 mgI/ml, 100 ml (300PP) or conventional drip infusion method using Iohexol 300 mgI/ml, 100 ml (300DI). Enhancement effects of the liver parenchyma, the aorta and the spleen at upper, middle and lower levels of the liver were evaluated with increased attenuation on pre- and postcontrast CT. And intrahepatic contrast was evaluated with attenuation difference between liver parenchyma and intrahepatic vessels on postcontrast CT. In result, 300PP kept better enhancement effects and obtained better intrahepatic contrast than 300DI at the each level of the liver, and 350PP was still better than 300PP. The analysis of relationship between intrahepatic contrast and body weight suggested that 300PP was the optimal choice for the cases with 40-50 kg body weight and 350PP was for the ones with 50-60 kg as the infusion method of routine contrast enhanced CT. And the dose of contrast media seemed to be more needed for the cases over 60 kg body weight. 350PP and 300PP were concluded as useful, safe and simple methods for routine contrast enhanced CT of the liver.     

多层螺旋CT低剂量高浓度对比剂腹部血管成像应用研究

目的:探讨多层螺旋CT应用低剂量、高浓度对比剂腹部血管成像的可行性.方法:40例腹部CT血管成像(CTA)分为2组,A组:采用300 mg I/ml对比剂剂量为100 ml、生理盐水30 ml;B组:采用400 mg I/ml对比剂剂量为60 ml、生理盐水30 ml.注射流率均为4 ml/s.根据原始图像和最大强度投影(MIP)像,评价两组病例腹主动脉及其分支、肾动脉及其分支的显示程度;并测量动脉内对比剂的浓度.结果:两组病例均清晰显示腹主动脉、腹腔干、肝总动脉、脾动脉、肠系膜上动脉、肾动脉及其分支;两组动脉内的对比剂浓度虽然均维持在较高的水平,但B组明显高于A组,差异有显著性意义.肾动脉及其分支显示程度评分,B组明显优于A组,两组间存在显著性差异.结论:多层螺旋CT腹部血管成像使用低剂量、高浓度对比剂可以满足临床需要.     

Four- and Eight-Channel Aortoiliac CT Angiography: A Comparative Study

Purpose To compare performance parameters, contrast material load and radiation dose in a patient cohort having aortoiliac CT angiography using 4- and 8-channel multidetector CT (MDCT) systems.Methods Eighteen patients with abdominal aortic aneurysms underwent initial 4-channel and follow-up 8-channel MDCT angiography. Both the 4- and 8-channel MDCT systems utilized a matrix detector of 16 × 1.25 mm rows. Scan coverage included the abdominal aorta and iliac arteries to the level of the proximal femoral arteries. For 4-channel MDCT, nominal slice thickness and beam pitch were 1.25 mm and 1.5, respectively, and for 8-channel MDCT they were 1.25 mm and 1.35 or 1.65 respectively. Scan duration, iodinated contrast material load and mean aortoiliac attenuation were compared retrospectively. Comparative radiation dose measurements for 4- and 8-channel MDCT were obtained using a multiple scan average dose technique on an abdominal phantom.Results Compared with 4-channel MDCT, 8-channel MDCT aortoiliac angiography was performed with equivalent collimation, decreased contrast load (mean 45% decrease: 144 ml versus 83 ml of 300 mg iodine/ml contrast material) and decreased acquisition time (mean 51% shorter: 34.4 sec versus 16.9 sec) without a significant change in mean aortic enhancement (299 HU versus 300 HU, p > 0.05). Radiation dose was 2 rad for the 4-channel system and 2/1.5 rad for the 8-channel system at 1.35/1.65 pitch respectively.Conclusion Compared with 4-channel MDCT, aortoiliac CT angiography with 8-channel MDCT produces equivalent z-axis resolution with decreased contrast load and acquisition time without increased radiation exposure.     

Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro

PURPOSE: To compare the cytotoxic effects of dimeric and monomeric iodinated contrast media on renal tubular cells in vitro with regard to osmolality. MATERIALS AND METHODS: LLC-PK1 cells were incubated with ioxithalamate, ioversol, iomeprol-300, iomeprol-150, iodixanol, iotrolan, and hyperosmolar mannitol solutions for 1-24 hours at concentrations from 18.75 to 150 mg of iodine per milliliter. Cytotoxic effects were assessed with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Data were analyzed with one-way analysis of variance; post hoc tests were performed. RESULTS: At equal iodine concentrations, ioxithalamate showed stronger cytotoxic effects than did other contrast media (MTT conversion for ioxithalamate was 4% vs that for ioversol of 32%, that for iomeprol-300 of 34%, that for iodixanol of 40%, and that for iotrolan of 41% of undamaged control cells at 75 mg of iodine per milliliter, n = 61-90, P < .001); there was no significant difference between low-osmolar monomeric and iso-osmolar dimeric contrast media (P > .05). At equal molarity, dimeric contrast media induced significantly stronger cytotoxic effects than did low-osmolar monomeric contrast media (40% for iodixanol and 41% for iotrolan vs 64% for ioversol and 59% for iomeprol-300 at 98.5 mmol/L, n = 61-75, P < .001). At equimolar concentrations, both dimeric contrast media showed stronger cytotoxic effects than did iso-osmolar formulation of iomeprol-150 (51% for iodixanol and 50% for iotrolan vs 77% for iomeprol-150 at 98.5 mmol/L, n = 35-40, P < .001). Mannitol solutions induced weaker cytotoxic effects than did corresponding contrast media compounds (74% for mannitol-520 vs 34% for iomeprol-300 and 41% for mannitol-1860 vs 4% for ioxithalamate, P < .001). CONCLUSION: Besides hyperosmolality, direct cytotoxic effects of contrast media molecules contribute to their cytotoxic effects. Results of this study indicate that dimeric contrast media molecules have a greater potential for cytotoxic effects on proximal renal tubular cells in vitro than do monomeric contrast media molecules.     

Omnipaque and urografin in arthrography of the knee

The first experience with Omnipaque in arthrography of the knee in patients is reported. Forty arthrographies were performed using either Omnipaque 350 mg I/ml or Urografin 370 mg I/ml at random. The low-osmolar non-ionic Omnipaque showed a tendency for pain of shorter duration and lower incidence of hydrops. A significantly lower incidence of complaints of tension and swelling and assessed reactive synovitis was demonstrated. Both contrast media produced excellent synovial coating on standard series, but Omnipaque showed a slower decrease in attenuation.     

Using thoracic helical CT to assess iodine concentration in a small volume of nonionic contrast medium during vascular opacification: a prospective study

OBJECTIVE: The goal of the study was to assess whether, using thoracic helical CT, diagnostic mediastinal and hilar vascular enhancement can be obtained with a small amount of nonionic contrast material (80 ml) injected at a relatively slow rate (2 ml/sec). SUBJECTS AND METHODS: One hundred twenty patients (60 in their fourth decade of life and 60 in their seventh decade of life) referred for contrast-enhanced thoracic CT for malignancies or infections prospectively entered the study. They were randomly assigned to be given one of three iodine concentrations of a nonionic contrast material: 250 mg/ml (1250), 300 mg/ml (1300), and 350 mg/ml (1350). Two radiologists independently graded perivenous artifacts and arterial enhancement of mediastinal and hilar vessels on a 4-point scale: 1, poor; 2, fair; 3, good; and 4, excellent. Measurements of arterial attenuation values (quantitative assessment) were obtained on the aorta and pulmonary artery. RESULTS: Mean scores were equal to or greater than 3 for all vessels only using 1350. The higher the iodine concentration was, the higher the mean score, but there was a statistically significant difference only between scores obtained with 1350 and those obtained with 1300 or 1250. Mean scores were higher for the patients in their seventh decade of life than those in their fourth decade; however, there was no statistically significant difference between scores of the two decade groups. We found a highly significant statistical relationship between scores and arterial attenuation values. CONCLUSION: During contrast-enhanced helical CT examinations for general thoracic evaluations, good opacification of central vascular structures is obtained with a low volume of high iodine concentration nonionic contrast medium.     

Comparison of iodixanol 270 with iohexol 300 in infrapopliteal arteriography. Digital densitometric analysis of angiographic opacification.

PURPOSE: To compare iodixanol 270 mg I/ml with iohexol 300 mg I/ml in infrapopliteal arteriography by measuring digital densitometric vessel opacification and by visually assessing angiographic enhancement. MATERIAL AND METHODS: In a double-blind, dual-balanced, 4-sequence cross-over design, 50 claudicant patients received two contrast media injections (10 min interval) in the superficial femoral artery. Digital angiography was performed at 8 frames/s and time-density curves with a circular region of interest over a distal calf artery were generated. A mixed, linear model was used to identify effects influencing the density measurements. Subjective evaluation of the image quality was made independently by two observers. RESULTS: No statistically significant difference between the contrast media was revealed in the analysis of the densitometric measurements (p=0.14) nor in the subjective visual evaluation (p=0.74). However, the mean density at the time of maximum opacification was higher after the first injection than that after the second injection (p=0.02). There was a tendency towards lower intensity of warmth during injection of iodixanol 270 than during injection of iohexol 300. CONCLUSION: In patients with severe occlusive atherosclerotic disease, iodixanol yielded the same image quality as iohexol in infrapopliteal arteriography, in spite of the 30 mg I/ml lower iodine concentration.     

Evaluation of two injection protocols by time-density curves for possible application to hepatic dynamic and upper abdominal CT angiography in MDCT: high concentration (350 mgI/ml) with conventional volume (100 ml) vs. conventional concentration (300 mgI/ml) with larger volume (150 ml) and higher injection rate

The purpose of this study was to compare two different injection protocols for possible application to hepatic dynamic CT and CT angiography of the upper abdomen. Single-level dynamic CT scans through the level of the porta heapatis were performed with an MDCT unit every 3 sec in 32 patients using protocol A (350 mgI/ml iodine contrast medium, total volume 100 ml, injection rate 3.0 ml/sec), and in 39 patients using protocol B (300 mgI/ml, 150 ml, 4.5 ml/sec). Injection duration was kept the same in the two protocols. Time-density curves of the abdominal aorta (Ao), liver (L), and portal vein (PV) were created and compared. Peak enhancements were significantly higher in protocol B than in protocol A, in all of Ao, L, and PV. Time to peak enhancement was shorter in protocol B than in protocol A, reaching statistical significance in Ao and PV, but not in L. The duration of the arterial phase was shorter in protocol B than in protocol A, but the difference was not statistically significant. Our data suggest the superiority of protocol B over protocol A, for possible application to hepatic dynamic CT and CT angiography of the upper abdomen in MDCT.     

Iohexol and ioxithalamate for intravenous urography. A comparative parallel study

Omnipaque (iohexol) 350 mg I/ml has been compared with Telebrix (ioxithalamate) 380 mg I/ml in 48 patients undergoing intravenous urography. The contrast medium dose corresponded to 400 mg I/kg body weight. No cardiovascular reactions (BP and pulse rate) were observed. Subjective reactions occurred somewhat more frequently after Telebrix than after Omnipaque. Sensation of warmth was significantly less with Omnipaque (p less than or equal to 0.05). The overall radiological quality was equally good for the two contrast media.     

Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography

PURPOSE: To compare the uniformity of aortoiliac opacification obtained from uniphasic contrast medium injections versus individualized biphasic injections at computed tomographic (CT) angiography. MATERIALS AND METHODS: Thirty-two patients with an abdominal aortic aneurysm underwent CT angiography. In 16 patients (group 1), 120 mL of contrast material was administered at a flow rate of 4 mL/sec. In the other 16 patients (group 2), biphasic injection protocols were computed by using mathematic deconvolution of each patient's time-attenuation response to a standardized test injection. Attenuation uniformity was quantified as the "plateau deviation" of enhancement values, which were calculated as the SD of the time-contiguous attenuation values observed during the 30-second scanning period. RESULTS: Group 2 patients received between 77 and 165 mL (mean, 115 mL) of contrast medium. Initial flow rates ranged from 4.1 to 10.0 mL/sec (mean, 6.8 mL/sec) for the first 4-6 seconds; continuing flow rates ranged from 2.0 to 4.8 mL/sec (mean, 3.1 mL/sec) for the remaining 24-26 seconds. The plateau deviation was significantly smaller in group 2 patients (19 HU) versus group 1 patients (38 HU, P <.001). CONCLUSION: At CT angiography, tailored biphasic injections led to more uniform aortoiliac enhancement, compared with standard uniphasic injections of contrast medium.     

Iohexol in coronary angiography. A double blind investigation

Iohexol 350 mg I/ml (Omnipaque) was compared with the routine contrast medium meglumine, Na-Ca-metrizoate 370 mg I/ml (Isopaque Coronar) in coronary angiography in 30 patients. A randomized, double blind, crossover design was employed. Angiographic image quality, ECG, heart rate, aortic blood pressure and adverse reactions were recorded. Excellent image quality was obtained with both media. Except for one single event of hypotension, only few and minor changes in the parameters measured were recorded. No distinct difference between the two media was found. Iohexol seems to be suitable for selective coronary angiography.     

不同碘浓度对比剂在肾脏MSCT增强扫描中的作用对比

目的:探讨300mgI/ml对比剂与400mgI/ml对比剂对肾脏MSCT多期增强扫描的强化作用。方法:将40例疑肾脏病变的患者随机分成两组,每组20例,分别行肾脏平扫及给予碘必乐300(300mg I/ml)与碘迈伦400(400mg I/ml)的多期增强MSCT扫描。在对比剂开始注射后18s、30s、80s、3~5min扫描。测量各期增强扫描腹主动脉、双肾动脉、双肾静脉、双肾皮质、双肾髓质、双肾盂、肾脏病变的CT强化值。观察上述结构的强化情况。结果:使用400mgI/ml对比剂组在18s与30s采集,所检测的血管与肾各结构强化均值与300mgI/ml对比剂组相比,差异有显著性意义(P<0.01),80s采集,肾动脉、肾静脉、肾髓质强化均值与300mgI/ml对比剂组相比,差异有显著性意义(P<0.01),3~5min采集,肾静脉与肾盂强化均值与300mgI/ml对比剂组相比,差异有显著性意义(P<0.01)。结论:高碘浓度对比剂对肾血管的显示优于标准碘浓度对比剂,并可降低对比剂用量。肾脏MSCT高碘浓度对比剂增强扫描在对比剂开始注射后30s与延时3~5min采集较合理。     

Effect of varying injection rates of a saline chaser on aortic enhancement in CT angiography: phantom study

The effect of varying injection rates of a saline chaser on aortic enhancement in computed tomography (CT) angiography was determined. Single-level, dynamic CT images of a physiological flow phantom were acquired between 0 and 50 s after initiation of contrast medium injection. Four injection protocols were applied with identical contrast medium administration (150 ml injected at 5 ml/s). For baseline protocol A, no saline chaser was applied. For protocols B, C, and D, 50 ml of saline was injected at 2.5 ml/s, 5 ml/s, and 10 ml/s, respectively. Injecting the saline chaser at twice the rate as the contrast medium yielded significantly higher peak aortic enhancement values than injecting the saline at half or at the same rate as the contrast medium (P < 0.05). Average peak aortic enhancement (HU) measured 214, 214, 218, and 226 for protocols A, B, C, and D, respectively. The slower the saline-chaser injection rate, the longer the duration of 90% peak enhancement: 13.6, 12.2, and 11.7 s for protocols B, C, and D, respectively (P > 0.05). In CT angiography, saline chaser injected at twice the rate as the contrast medium leads to increased peak aortic enhancement and saline chaser injected at half the rate tends towards prolonging peak aortic enhancement plateau.     

Contrast timing in computed tomography: effect of different contrast media concentrations on bolus geometry

Objective

To assess the effect of low-osmolar, monomeric contrast media with different iodine concentrations on bolus shape in aortic CT angiography.

Materials and methods

Repeated sequential computed tomography scanning of the descending aorta of eight beagle dogs (5 male, 12.7 ± 3.1 kg) was performed without table movement with a standardized CT scan protocol. Iopromide 300 (300 mg I/mL), iopromide 370 (370 mg I/mL) and iomeprol 400 (400 mg I/mL) were administered via a foreleg vein with an identical iodine delivery rate of 1.2 g I/s and a total iodine dose of 300 mg I/kg body weight. Time-enhancement curves were computed and analyzed.

Results

Iopromide 300 showed the highest peak enhancement (445.2 ± 89.1 HU), steepest up-slope (104.2 ± 17.5 HU/s) and smallest full width at half maximum (FWHM; 5.8 ± 1.0 s). Peak enhancement, duration of FWHM, enhancement at FWHM and up-slope differed significantly between iopromide 300 and iomeprol 400 (p < 0.05). Except for enhancement at FWHM there were no significant differences between iopromide 300 and iopromide 370 and iopromide 370 and iomeprol 400 (p > 0.05).

Conclusions

Low viscous iopromide 300 results in a better defined bolus with a significantly higher peak enhancement, steeper up-slope and smaller FWHM when compared to iomeprol 400. These characteristics potentially affect contrast timing.     

Effects of high- and low-osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats. A comparison between ioxithalamate, iopamidol, iohexol and ioxaglate

The effects of a slow intravenous injection of contrast media (CM) on renal function and haemodynamics were investigated in euvolaemic and dehydrated rats. Iodine-equivalent doses (1600 mg I/kg body weight) of ioxithalamate, ioxaglate, iopamidol and iohexol were used. Glomerular filtration rate (GFR) and renal plasma flow (RPF) were assessed with clearance techniques. In euvolaemic rats no statistically significant decrease in GFR or RPF was found after CM injections. In the dehydrated rats the changes in GFR were more pronounced and this was significantly decreased in the ioxithalamate and iopamidol groups while RPF was still not decreased. This study indicates that dehydration potentiates adverse effects of CM on GFR and that there may be differences between the effects of low-osmolar and high-osmolar CM on GFR and also between different low-osmolar CM.     

64-Slice CT angiography of the abdominal aorta and abdominal arteries: comparison of the diagnostic efficacy of iobitridol 350 mgI/ml versus iomeprol 400 mgI/ml in a prospective, randomised, double-blind multi-centre trial

Purpose

The purpose of this study was to assess the influence of iodine concentration on diagnostic efficacy in multi-detector-row computed tomography (MDCT) angiography of the abdominal aorta and abdominal arteries.

Methods

IRB approval and informed consent were obtained. In this double-blind trial, patients were randomised to undergo MDCT angiography of the abdominal arteries during administration of iobitridol (350 mgI/ml) or iomeprol (400 mgI/ml). Each centre applied its own technique for delivery of contrast medium, regardless of iodine concentration. Diagnostic efficacy, image quality, visualisation of the arterial wall and arterial enhancement were evaluated. A total of 153 patients received iobitridol and 154 received iomeprol.

Results

The ability to reach a diagnosis was “satisfactory” to “totally satisfactory” in 152 (99.3%) and 153 (99.4%) patients respectively. Image quality was rated as being “good” to “excellent” in 94.7 and 94.8% segments respectively. Similar results were observed for image quality of arterial walls (84.3 vs. 83.2%). The mean relative changes in arterial enhancement between baseline and arterial phase images showed no statistically significant differences.

Conclusion

This study demonstrated the non-inferiority of the 350 versus 400 mgI/ml iodine concentration, in terms of diagnostic efficacy, in abdominal MDCT angiography. It also confirmed the high robustness and reliability of this technique across multi-national practices.     

Evaluation of renal transplant donors with 16-section multidetector CT angiography: comparison of contrast media with low and high iodine concentrations

PURPOSE: To compare the degree of contrast enhancement, image quality, and accuracy of renal computed tomographic (CT) angiography performed with a 16-detector row CT unit and equal iodine doses of low- and high-iodine-concentration contrast medium in the evaluation of renal transplant donors. MATERIALS AND METHODS: Eighty donors scheduled to undergo renal CT angiography with 16-detector row CT were administered nonionic contrast media with two iodine concentrations. The first group (group A, n=40) received a contrast medium with 300 mg of iodine per milliliter, and the second group (group B, n=40) received a contrast medium with 370 mg of iodine per milliliter. An equal iodine dose of 550 mg per kilogram body weight was given to both groups. Contrast enhancement was quantified by measuring attenuation in the abdominal aorta and in both renal arteries. Subjective assessment of contrast enhancement, quality of reformatted images, and visualization of branch order of renal arteries were rated with a 5-point scale. The number of renal arteries and veins seen at CT was correlated with the results at surgery. RESULTS: The mean enhancement values in group B were significantly greater (P<.001) than those in group A. The mean HU (+/-standard deviation) in groups A and B were 298+/-76 and 344+/-75, respectively, in the aorta, 284+/-74 and 331+/-71 in the right renal artery, and 285+/-72 and 329+/-73 in the left renal artery. The mean enhancement, image quality, and branch orders visualized were rated better in group B than in group A (P<.01). The accuracies for correctly identifying renal arteries and veins, respectively, were 91% and 95% for group A and 96% and 96% for group B. CONCLUSION: Renal donor CT angiography with a contrast medium of 370 mg of iodine per milliliter provides greater enhancement and image quality compared with a contrast medium of 300 mg of iodine per milliliter. The diagnostic accuracies were similar.     

MSCT肝脏增强扫描中的碘对比剂应用研究

目的:探讨MSCT肝脏增强扫描中碘对比剂浓度及注射速率对肝脏强化效果的影响。方法:90例受检者按对比剂碘浓度300mg/ml、350mg/ml、370mg/ml及注射速度3.0ml/s、4.0ml/s、5.0ml/s分成9组,各10例,保持每位检查者碘总量一致,即390mgI/kg体重。90例受检者均使用Siemens Somatom definition螺旋CT和Medrad Stellant双筒高压注射器行肝脏动态增强扫描。双盲式观察、分析肝脏峰值时间(Time to Peak)及强化峰值(Peak Contrast Enhance-ment)。结果:随着对比剂注射速度的增加肝脏各期峰值时间提前、强化峰值增高;对比剂碘浓度的增加肝脏强化各期峰值时间亦提前,但峰值变化不大,高浓度对比剂较低浓度肝脏强化峰值相近。结论:不同碘对比剂的浓度、注射速度对肝脏强化程度存在影响,低浓度对比剂、高速率注射、个性化给药可以得到满意的强化效果。